Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Moleculin Biotech, Inc.

Clinical trials sponsored by Moleculin Biotech, Inc., explained in plain language.

Moleculin Biotech, Inc. MBRX NASDAQ

A clinical-stage biopharmaceutical company developing treatments for hard-to-treat cancers.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New drug combo aims to beat back relapsed leukemia

Disease control Recruiting now

This study tests a new chemotherapy drug, L-Annamycin, combined with standard cytarabine in adults with acute myeloid leukemia (AML) that has come back or not responded to first treatment. About 312 participants will receive either the new drug combo or a placebo plus cytarabine.…

Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC